Fundstrat's Flagship Fund Gets a Shake-Up: GRNY Outlook
Finance

Fundstrat's Flagship Fund Gets a Shake-Up: GRNY Outlook

authorBy Robert Kiyosaki
DateJun 25, 2026
Read time2 min

Fundstrat's primary investment vehicle, GRNY, has once again secured a 'Buy' rating. This comes after demonstrating a notable lead over the S&P 500, surpassing it by 2.5 percentage points since July 2025. This strong performance highlights the fund's resilience and strategic positioning in a dynamic market environment.

A significant development for GRNY is the rebalancing of its portfolio. The fund has strategically decreased its allocation to the technology sector to below 30% while increasing its investments in cyclical industries. This move is designed to create a more diversified and robust portfolio, aiming to capitalize on a broader market rally and mitigate risks associated with overconcentration in a single sector.

While the technical indicators for GRNY present a mixed picture, the underlying fundamentals remain strong. The fund boasts a weighted-average long-term EPS growth rate of nearly 14% and trades at a P/E multiple in the mid-20s, reflecting a premium compared to the S&P 500. Investors should monitor the key support level at $26, as price action near this point could dictate short-term movements, with potential downside to $24.75 or upside to $29.50. This blend of strategic rebalancing and solid growth prospects suggests a compelling opportunity.

The proactive management and strategic adjustments within the GRNY fund exemplify a forward-thinking approach to investment. By adapting its portfolio to evolving market conditions, GRNY aims to not only sustain its outperformance but also to offer investors a balanced and growth-oriented option. This commitment to strategic allocation and a positive outlook can serve as an inspiring example for those seeking prudent and effective investment strategies.

More Articles
Finance
Memory Chip Market Trends: Micron and SK Hynix Reshaping the Landscape
Micron Technology's recent earnings demonstrate strong performance fueled by AI-driven demand and positive margin projections. The article explores how both Micron and SK Hynix could potentially revolutionize the historical cyclicality of the memory market, particularly with the escalating demand for High Bandwidth Memory (HBM) chips. A 'Buy' rating is maintained for Micron, projecting significant upside, while SK Hynix is noted as undervalued, poised for re-evaluation with improved investor access and continued AI growth.
By Robert KiyosakiJun 25, 2026
Finance
Investor Optimism Surges in Latest Sentiment Survey
The most recent AAII Sentiment Survey reveals a notable increase in individual investor optimism regarding the short-term stock market outlook. Bullish sentiment saw a significant rise of 8.4 percentage points, reaching 44.9%. Conversely, both neutral and bearish sentiments experienced decreases, with neutral sentiment falling by 5.1 percentage points to 18.9% and bearish sentiment declining by 3.2 percentage points to 36.1%. This shift indicates a growing confidence among individual investors in the market's upward trajectory.
By Suze OrmanJun 25, 2026
Finance
MapLight Therapeutics' Schizophrenia Drug: A Balanced Outlook Ahead of Phase 2 Results
MapLight Therapeutics has been given a Hold rating as it approaches the Phase 2 ZEPHYR readout for ML-007C-MA, a drug aimed at treating schizophrenia. This experimental treatment is seen as a strong competitor to existing therapies like Cobenfy, potentially offering improved tolerability, easier administration, and enhanced effectiveness. While an earlier drug, ML-004, did not meet its primary goal in autism, there is still hope for a specific patient group. My valuation model suggests that MapLight Therapeutics' current stock price accurately reflects its fair value, indicating an even risk-reward balance before the upcoming study results.
By Fareed ZakariaJun 25, 2026
Finance
Understanding Overdraft Protection: Mechanisms, Considerations, and Future Trends
Overdraft protection is an optional banking service that prevents transactions from being declined when they exceed an account's available funds. This service links a primary account to a backup, such as a savings account or credit card, to cover shortfalls. While it prevents rejected transactions and associated fees, it can incur its own costs, including transfer fees and, if a credit card is used, cash advance fees and interest. Recent trends indicate a shift towards reducing or eliminating these fees due to public and regulatory pressure.
By Lisa JingJun 25, 2026
Finance
Heidelberg Materials: Not Yet Attractive, But May Become So Later
Despite recent valuation declines, Heidelberg Materials remains a 'HOLD' with a reiterated €135/share price target. Growth is driven by pricing, not volume, making HDLMY's earnings trend fragile amid weak European demand and macro uncertainty. Buybacks are currently value-destructive, as earnings yield does not exceed WACC, and fundamentals do not justify a premium multiple. Sector headwinds, cost pressures, and slow recovery limit upside; risk/reward is not attractive enough to upgrade from 'HOLD.'
By David RubensteinJun 25, 2026